Developing an Anti-Tumor Therapy: Expression of mTRAIL Cytokine in Escherichia coli
2012-04-18
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Developing an Anti-Tumor Therapy: Expression of mTRAIL Cytokine in Escherichia coli
Alternative title
Authors
Published Date
2012-04-18
Publisher
Type
Presentation
Abstract
The goal of this project is to develop a bacteria-based therapy for cancer. Since conventional radiation and chemotherapies attack cells on the outside of the tumors, another strategy is needed to kill cells in the interior of the tumor. Solid cancerous tumors often have nearly anaerobic cores due to poor blood circulation, and some anaerobic bacteria are known to enter tumor cells and reproduce. If these bacteria can be engineered to produce cytokines that will activate the immune system, then all of the tumor cells could be eliminated. Here we show the successful modification of a bacterial plasmid in Escherichia coli to express and secrete a known human apoptotic factor (TRAIL), which aids in controlled cell death of cancerous cells. Once expression is optimized, this plasmid will be introduced into an attenuated strain of Salmonella enteria Typhimurium, which is known to invade tumor cells. This bacterium can then be tested as a therapy in mouse models of cancer.
Description
Faculty adviser: Dr. Janet Schottel, Ph.D.
Related to
Replaces
License
Series/Report Number
Funding information
This research was supported by the Undergraduate Research Opportunities Program (UROP).
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Arries, Cade. (2012). Developing an Anti-Tumor Therapy: Expression of mTRAIL Cytokine in Escherichia coli. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/123437.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.